Motor Performance Improvement After Visual Rehabilitation
VRvisual
Analysis of Motor Performance Improvement Following Visual Rehabilitation Treatment in Individuals with Visual Field Defects Due to Acquired Brain Injury
1 other identifier
interventional
30
1 country
2
Brief Summary
Acquired brain injury" refers to brain damage that impacts neurological processing, making daily activities challenging and often causing vision issues like binocular dysfunction, oculomotor problems, and visual field loss. In Spain, visual rehabilitation is limited, although it is more common in other countries. These patients generally need an interdisciplinary approach involving professionals like physiotherapists and optometrists and often face mobility, balance, and spatial perception difficulties. Treatment tools include lenses, prisms, and technologies like virtual reality (VR). The Visionary VR program, presented by Dr. Portela, has shown promising results in visual field recovery by stimulating the affected area. Visual rehabilitation is based on brain plasticity and involves three key strategies: Prisms to expand the visual field. Compensatory therapy to improve eye movement. Restitution therapy to restore the visual field.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2024
CompletedFirst Posted
Study publicly available on registry
November 20, 2024
CompletedStudy Start
First participant enrolled
November 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedNovember 20, 2024
October 1, 2024
11 months
November 11, 2024
November 18, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Visual field
The threshold test will be used in a 30-2 field size with fixation monitoring.
15 minutes
Balance
The stabilometric study will be conducted using the Podoprint® pressure platform (Grupo Namrol, Barcelona, Spain). A balance assessment will be conducted after 6 sessions and after 12 sessions of treatment.
15 minutes
Secondary Outcomes (16)
Visual Acuity
2 minutes
Subjective refraction
5 minutes
Worth test
1 minute
Ramdom Dot 2
2 minutes
Cover Test
1 minute
- +11 more secondary outcomes
Study Arms (1)
VR Study Group
EXPERIMENTALOnce the patient is included in the study, 12 weekly sessions of visual rehabilitation, each lasting 45 minutes, will be scheduled. A Virtual Reality device will be used along with the Visionary Sport visual therapy software.
Interventions
The study includes 12 weekly 45-minute visual rehabilitation sessions using a Virtual Reality device with Visionary Sport software. Originally designed for sports visual training, this software features gamified exercises to improve visual response times under professional supervision. Activities include games to enhance fixation, ocular motility, peripheral vision, and vergence. The "Peripheral Attention" activity trains reaction times to static stimuli perceived in the peripheral retina, adjustable to the patient's visual field defect. Stimuli can be placed at 10, 20, or 30 degrees in the peripheral field. The VR headset (Vive Focus 3) includes an eye tracker to monitor and adapt stimuli based on patient performance. Patients also perform 30 minutes of daily exercises at home, using proprietary software and Tobii 4C and 5C eye-tracking devices for ocular monitoring.
Eligibility Criteria
You may qualify if:
- Adult subjects diagnosed with acquired brain injury either from a stroke or trauma.
- Subjects without cognitive impairment.
- Subjects without pre-existing musculoskeletal disorders prior to the acquired brain injury.
- Subjects without hemineglect.
- Subjects with more than 6 months of progression since the brain injury.
- Subjects who have an electronic device such as a computer and internet access to perform the exercises at home.
- Subjects with altitudinal visual field loss, hemianopia, or quadrantanopia with the central field preserved and at least 0.5 visual acuity.
You may not qualify if:
- Not signing the informed consent.
- Previous severe mental pathology to eliminate possible confounding factors if their daily activities are already affected.
- Uncontrolled epilepsy.
- Subjects with glaucoma or retinal pathologies affecting the visual field.
- Subjects with previous ocular surgery (cataract or refractive surgery) with less than 6 months of progression.
- Subjects who are not stable in any associated clinical pathology or otherwise diagnosed.
- Subjects who have previously undergone visual rehabilitation for the field defect.
- Not performing the proposed home exercises.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Zaragoza
Zaragoza, Zaragoza, 50009, Spain
University of Zaragoza
Zaragoza, Zaragoza, 50009, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Maria José López de la Fuente, PhD
Universidad de Zaragoza
- STUDY CHAIR
Jorge Pérez Rey, PhD
Universidad de Zaragoza
- STUDY CHAIR
Naiara Díaz Marín, MSc
Universidad de Zaragoza
- STUDY CHAIR
Javier Mateo Gabás, PhD
Universidad de Zaragoza
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D. from the University of Zaragoza
Study Record Dates
First Submitted
November 11, 2024
First Posted
November 20, 2024
Study Start
November 29, 2024
Primary Completion
October 31, 2025
Study Completion
December 31, 2025
Last Updated
November 20, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share